精品国产一区二区桃色

Journal News

A jellyfish model to study optogenetics

Adenike Shittu
By Adenike Shittu
Dec. 26, 2023

Box jellyfish, an ancient invertebrate species, have evolved separately from vertebrate animals for over 500 million years. Unlike other jellyfish species, box jellyfish have well-developed eyes similar to those of vertebrates. These eyes have a light-sensitive protein receptor called rhodopsin that enables them to process visual cues such as twilight and color perception, which are essential for their survival.

Shino Inukai, Kota Katayama, Hideki Kandori and colleagues at the Nagoya Institute of Technology in Japan have found that the rhodopsin in jellyfish is similar to that in vertebrates. In a published in the Journal of Biological Chemistry, they describe the structural similarities, photoreaction activity and highly developed visual function of rhodopsin in box jellyfish and vertebrates.

Box jellyfish have the only animal rhodopsin known to activate Gs protein. G proteins are guanine nucleotide-binding proteins. They can transmit signals from receptors on the cell surface to the inside of the cell, where they regulate a wide range of cellular functions and processes. These include maintenance of cellular homeostasis, response to external stimuli, neurotransmission and sensory perception.

Box jellyfish’s rhodopsin, or JelRh, is the only animal rhodopsin that researchers have shown to transduce the G protein signaling pathways. Because jellyfish rhodopsin can control the G proteins’ signaling pathway with light, it is a promising new optogenetics tool.

The authors used JelRh to study how G proteins regulate cyclic adenosine monophosphate induction, or cAMP, which is widely associated with biological processes such as circadian rhythms, cardiac function and behavioral control. In the words of the authors, “the development of jellyfish rhodopsin can be used as a tool to elucidate the molecular mechanisms of diseases caused by abnormal signal transduction through Gs protein,” which include nephrogenic diabetes insipidus and obesity.

While this study shows promising findings, the authors acknowledge certain limitations in this model. The authors’ discovery of JelRh’s distinctive hydrogen bonding network surrounding the retinal chromophore hints at intermediate structural variance in rhodopsin in other invertebrates and vertebrates.

Researchers have not yet characterized other essential defining factors of JelRh. Therefore, as a future work, the authors propose to conduct site-directed mutation measurements to determine the key residues, in GPCR activation. Future structural studies will focus on the photoreaction of the active state to explore how JelRh triggers Gs protein–mediated phototransduction cascade. Specifically, the spectroscopy-based structural study of photoreaction dynamics of Gs-coupled animal rhodopsin will provide insights into the activation mechanism of G protein–coupled receptors.

Looking forward, the team proposes to clarify the light activation and signal transduction mechanisms of JelRh, the only animal rhodopsin that has been shown to transduce Gs signal. Specifically, the aim is to decipher the molecular intricacies underlying the activation of Gs protein.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Adenike Shittu
Adenike Shittu

Adenike Shittu is a biomedi颅cal research scientist who is passionate about science communication and an ASBMB Today contributing writer.

Get the latest from ASBMB Today

Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

RA patient blood reveals joint innerworkings
Journal News

RA patient blood reveals joint innerworkings

July 25, 2025

Researchers in the Netherlands use mass spectrometry to compare the proteome of plasma and synovial fluid in rheumatoid arthritis patients and find a correlation. Read more about this recent paper in Molecular & Cellular Proteomics.

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson鈥檚 fight for survival and hope. Without funding, science can鈥檛 鈥渃atch up鈥 to help the patients who need it most.

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease
Feature

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal 鈥 and just getting started.

Defeating deletions and duplications
News

Defeating deletions and duplications

July 11, 2025

Promising therapeutics for chromosome 15 rare neurodevelopmental disorders, including Angelman syndrome, Dup15q syndrome and Prader鈥揥illi syndrome.

Using 'nature鈥檚 mistakes' as a window into Lafora disease
Feature

Using 'nature鈥檚 mistakes' as a window into Lafora disease

July 10, 2025

After years of heartbreak, Lafora disease families are fueling glycogen storage research breakthroughs, helping develop therapies that may treat not only Lafora but other related neurological disorders.

Cracking cancer鈥檚 code through functional connections
News

Cracking cancer鈥檚 code through functional connections

July 2, 2025

A machine learning鈥揹erived protein cofunction network is transforming how scientists understand and uncover relationships between proteins in cancer.